Fluidigm Corporation Introduces First Integrated Fluidic Circuit Able to Perform 9,216 Simultaneous Real-Time PCR Experiments

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation today introduced its BioMark™ 96.96 Dynamic Array, a new integrated fluidic circuit (IFC) capable of performing 9,216 simultaneous real-time PCR experiments running TaqMan® assays in nanoliter quantities. This new generation IFC enables life science researchers to achieve new levels of cost and logistical efficiency and flexibility, as well as comprehensive profiling from miniscule amounts of sample.